Israel Englander’s Celularity CELU Stock Holding History

Israel Englander’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$871K	–	7011
2022 Q1	$871K	Buy	+10,000	New	+$599K	﹤0.01%	4666

Other funds holding CELU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return

Israel Englander's CELU Position: Q2 2024 in Review

Israel Englander sold out of Celularity (CELU) in Q2 2024, closing a stake of 17,012 shares — an estimated $89K sold.

Israel Englander first reported a position in CELU in Q4 2019 and held it in 16 quarters. The position peaked at $14.1M in Q1 2021. 26 funds tracked by Wall St. Rank hold CELU as of Q2 2024.

Israel Englander reported no remaining Celularity position as of Q2 2024 after selling out during the quarter.
Israel Englander sold 17,012 Celularity shares in Q2 2024, an estimated $89K.
Israel Englander first reported a position in Celularity in Q4 2019 and held it in 16 quarters.
Israel Englander's Celularity position peaked at $14.1M in Q1 2021.
26 funds tracked by Wall St. Rank held Celularity as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.